HPV Vaccine Awareness and Knowledge Among Women Living with HIV

被引:0
作者
L. T. Wigfall
S. A. Bynum
H. M. Brandt
J. R. Hébert
机构
[1] University of South Carolina,Department of Health Services Policy and Management, Arnold School of Public Health
[2] University of South Carolina,South Carolina Statewide Cancer Prevention and Control Program, Arnold School of Public Health
[3] Uniformed Services University of the Health Sciences,Department of Preventive Medicine and Biometrics, F. Edward Hébert School of Medicine
[4] University of South Carolina,Department of Health Promotion, Education, and Behavior, Arnold School of Public Health
[5] University of South Carolina,Department of Epidemiology and Biostatistics, Arnold School of Public Health
来源
Journal of Cancer Education | 2016年 / 31卷
关键词
Awareness; Cervical cancer; HIV-positive; HPV vaccine; Knowledge;
D O I
暂无
中图分类号
学科分类号
摘要
Cervical cancer risk is increased among women living with HIV (WLH). Human papillomavirus (HPV) vaccination has been shown to be safe and immunogenic among WLH. We examined HPV vaccine awareness and HPV knowledge among WLH. This cross-sectional study collected data from 145 WLH between March 2011 and April 2012. An interviewer-administered survey assessed HPV vaccine awareness and knowledge. Stata/IC 13 was used to perform chi-square tests and multivariate logistic regression analyses. Our sample was 90 % non-Hispanic black and 64 % earned <$10,000/year. Few (38 %) had heard of the HPV vaccine. Half (50 %) knew that HPV caused cervical cancer. HPV vaccine awareness was ten times higher among WLH who knew HPV caused cervical cancer (OR = 10.17; 95 % CI 3.82–27.06). HPV vaccine awareness is low among WLH. Cancer prevention efforts aimed at raising awareness about the HPV vaccine and increasing knowledge about HPV are necessary first steps in reducing cervical cancer disparities among WLH.
引用
收藏
页码:187 / 190
页数:3
相关论文
共 45 条
[1]  
Chin-Hong PV(2002)Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus Clin Infect Dis: Off Publ Infect Dis Soc Am 35 1127-1134
[2]  
Palefsky JM(1997)Human papillomavirus infection in women infected with the human immunodeficiency virus N Engl J Med 337 1343-1349
[3]  
Sun XW(2011)Cancer burden in the HIV-infected population in the United States J Natl Cancer Inst 103 753-762
[4]  
Kuhn L(2011)Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007 JAMA: J Am Med Assoc 305 1450-1459
[5]  
Ellerbrock TV(2007)Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis Lancet 370 59-67
[6]  
Chiasson MA(2014)Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep: Morb Mortal Wkly Rep Recomm Rep/ Centers Dis Control 63 1-30
[7]  
Bush TJ(2012)Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination J Acquir Immune Defic Syndr 61 390-399
[8]  
Wright TC(2013)HPV vaccination among young adult women: a perspective from Appalachian Kentucky Prev Chron Dis 10 E17-102
[9]  
Shiels MS(2015)Vaccination coverage among adults, excluding influenza vaccination—United States, 2013 MMWR Morb Mortal Wkly Rep 64 95-undefined
[10]  
Pfeiffer RM(undefined)undefined undefined undefined undefined-undefined